AIM ImmunoTech Inc.
AIM- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000946644
In the last 90 days, AIM ImmunoTech Inc. insiders filed 14 open-market purchases and 0 sales; 18 institutions reported holding it in 13F filings for Q3 2026, worth $177.0K in total; no superinvestor holds it.
Holders of 5% or more of AIM
Holders whose latest Schedule 13D or 13G filing reports 5% or more of AIM ImmunoTech Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Orca Capital AG | 13G | 9.90%1.79M shares | New | May 12, 20261 filing | May 12, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
16 Schedule 13D and 13G filings on AIM ImmunoTech Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| May 27, 20265:14 PM ET | Intracoastal Capital, LLCand 2 others | 13G | 0.00%0 shares | NewBelow 5% | May 20, 2026 | SEC |
| May 12, 20264:30 PM ET | Orca Capital AG | 13G | 9.90%1.79M shares | New | May 7, 2026 | SEC |
| Feb 14, 20254:55 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 4.99%3.35M shares | –Below 5% | Dec 31, 2024 | SEC |
| Dec 23, 202411:11 AM ET | Deutsch Toddand 3 others | 13D/A | 2.70%1.72M shares | –Below 5% | Dec 19, 2024 | SEC |
| Dec 17, 2024 | Deutsch Todd | 13D/AOld format | – | – | – | SEC |
| Nov 14, 2024 | Armistice Capital, LLC | 13GOld format | – | New | – | SEC |
| Sep 11, 2024 | Deutsch Todd | 13D/AOld format | – | – | – | SEC |
| Sep 3, 2024 | Deutsch Todd | 13D/AOld format | – | – | – | SEC |
| Aug 14, 2024 | Deutsch Todd | 13D/AOld format | – | – | – | SEC |
| Jul 30, 2024 | Deutsch Todd | 13D/AOld format | – | – | – | SEC |
| Jul 15, 2024 | Deutsch Todd | 13D/AOld format | – | – | – | SEC |
| Jan 3, 2024 | Deutsch Todd | 13D/AOld format | – | – | – | SEC |
| Aug 28, 2023 | Deutsch Todd | 13D/AOld format | – | – | – | SEC |
| Aug 7, 2023 | Deutsch Todd | 13D/AOld format | – | – | – | SEC |
| Jul 27, 2023 | Deutsch Todd | 13DOld format | – | New | – | SEC |
| Feb 8, 2021 | Hudson Bay Capital Management LP | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell AIM ImmunoTech Inc. shares.
No Form 144 notices for AIM ImmunoTech Inc. are on file.